bf/NASDAQ:FENC_icon.jpeg

NASDAQ:FENC

Fennec Pharmaceuticals Inc.

  • Stock

6.11

+1.16%

−3.13

USD last updated 13/08 01:59:42

Last Close

9.24

12/08 20:01

Market Cap

163.93M

Beta: 0.16

Volume Today

65.31K

Avg: 80.91K

PE Ratio

−11.72

PFCF: −16.43

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in Septembe...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    12342018-08-132020-08-052022-02-282023-11-062024-08-13

    Revenue (Estimate*)

    5M10M15M20M25M30M35M2018-08-132020-08-052022-02-282023-11-062024-08-13

    *Estimate based on analyst consensus